Altnagelvin Hospital

Trial EndoNET
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital and Belfast City Hospital
Information

Randomised controlled trial evaluating effectiveness of neoadjuvant endocrine treatment in post-menopausal women

Trial KEYNOTE-B49
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Randomised, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Metastatic Breast Cancer

Trial Lantern Pharma
Cancer Type Prostate Cancer
Hospital(s) Altnagelvin Hospital
Information

Biomarker analysis using fresh biopsy tissue

Trial MARECA
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

National study of management of breast cancer locoregional recurrence and oncological outcome

Click Here to view CancerHelpUK trial summary
Trial SMALL Trial
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

A Phase III, randomised, multi-centre trial addressing overtreatment of small screen-detected breast cancer by comparing standard surgery versus minimally invasive vacuum-assisted excision

Trial TROPION - 03
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)

Trial UKGPC
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital
Information

UK Genetics Prostate Cancer Study

Click Here to view CancerHelpUK trial summary